SCN1A and epilepsy: There are now more than 20 antiepileptic drugs available in the market that have different action mechanisms and targets.6 With limited information regarding the mechanism of epilepsies caused by SCN1A, it has been challenging for physicians to choose among drugs that synergistically control seizures while minimizing adverse effects.